Table 3.
Three MMSE groups and mortality
| MMSE 19–23 (n=119) | MMSE ≥23 (n=100) | MMSE ≤19 (n=65) | |
|---|---|---|---|
|
| |||
| All-cause mortality | |||
| Crude HR | Reference | 2.19 (0.57–8.37) | 4.72 (1.34–16.59) |
| Age, gender adjusted HR | Reference | 2.59 (0.63–10.61) | 5.92 (1.60–21.87) |
| Multivariable adjusted HRa | Reference | 3.30 (0.77–14.16) | 8.18 (2.05–32.54) |
| Cardiovascular mortality | |||
| Crude HR | Reference | 4.76 (0.56–40.77) | 9.01 (1.13–72.09) |
| Age, gender adjusted HR | Reference | 4.73 (0.52–42.75) | 10.39 (1.24–86.83) |
| Multivariable adjusted HRa | Reference | 6.55 (0.69–62.27) | 14.72 (1.65–131.16) |
Notes: Data are presented as HR (95% CI).
a
Model was further adjusted for age, gender, body mass index, current smokers, previous CVD, treatment group, fasting glucose, total cholesterol, uric acid, diastolic BP and eGFR.
Abbreviations: BP, blood pressure; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rat; HR, hazard ratio; MMSE, mini-mental state examination.